Recursion Pharmaceuticals YTD Return
The RXRX YTD return is -25.67% with dividends reinvested through 05/14/2026. Investors often use YTD return to compare year-to-date performance across securities because current calendar year return information is important for tax planning.
This page shows RXRX YTD return, annualized return, start and end dates, and the growth of a hypothetical $10,000 investment with dividends reinvested.
| RXRX YTD Return Table | ||||||||||||||||||||||||||||||
RXRX YTD return is presented with the assumption of reinvestments of any dividends on ex-date. |
| YTD Return Benchmarks |
|
Compare RXRX YTD return (see YTD Return Meaning) versus benchmarks: YTD Return S&P YTD Return Dow YTD Return Nasdaq 100 YTD Return Russell 2000 YTD Return Gold YTD Return 10 Year Treasury YTD Return By Sector |
| RXRX Share Performance |
| RXRX YTD Return Chart | |||
Also see: RXRX Average Annual Return | |||
| About Recursion Pharmaceuticals Inc |
| Recursion Pharmaceuticals, Inc. is a clinical-stage TechBio company decoding biology to industrialize drug discovery. Its Recursion Operating System (OS), a platform built across diverse technologies, enables the Co. to map and navigate trillions of biological and chemical relationships within the Recursion Data Universe. Co. integrates physical and digital components as iterative loops of atoms and bits scaling wet lab biology and chemistry data organized into virtuous cycles with computational tools to rapidly translate in silico hypotheses into validated insights and novel chemistry. Its clinical programs include REC-994, REC-2282, REC-4881 and REC-3964. The RXRX YTD return is shown above.
The YTD Return on the RXRX YTD return page and across the coverage universe of our site, is a measure of the total return for a given investment year-to-date for the current calendar year (up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely useful in the context of our country's tax system which taxes gains and income on a calendar year basis. Thus, researching Year-To-Date Returns is good practice for investors — whether RXRX YTD return or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the RXRX YTD return calculation (with any dividends reinvested as applicable), and to provide a coverage universe of many stocks and ETFs to be able to compare YTD returns. |
| RXRX Current Stock Quote |
Quotes delayed 20 minutes  Free RXRX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in YTD Return! | |
|
| YTD Return Peers |
| Recursion Pharmaceuticals (RXRX) is categorized under the Healthcare sector; to help you further research YTD return performance across stocks, below are some other companies in the same sector:
RXST YTD Return RYTM YTD Return RYZB YTD Return RZLT YTD Return SABS YTD Return SAGE YTD Return SANA YTD Return SAVA YTD Return SBFM YTD Return SBPH YTD Return More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.
Video: Don't Forget Dividends in YTD Return!